Psychological Support Interventions for Women With Endometriosis (ENDOPSY)
Condition(s) studied
Investigational drug(s) / intervention(s)
Individual Psychotherapy: Ten individual psychotherapy sessions (45 minutes each) delivered every two weeks for 5 months by trained psychologists.
Socio-Aesthetic Group Therapy: Six socio-aesthetic therapy workshops (2 hours each) every two weeks over 3 months, focusing on body image, sensory experience, and emotional expression.
Mixed Psychotherapy: Combined individual and group psychotherapy including alternating sessions and final integrative sessions matching the number and duration of individual and group interventions.
Study summary
Endometriosis is associated with severe pain, impaired quality of life and significant psychological distress. Psychological support may help improve emotional regulation, mental health, and quality of life in affected women. This randomized controlled trial evaluates the impact of three psychological support interventions-individual psychotherapy, socio-aesthetic group therapy, and a mixed approach combining both-on psychological symptoms and quality of life. Forty participants will be randomized into four parallel arms. The study hypothesis is that psychological support interventions improve psychological functioning and disease-related quality of life compared with no intervention, and that the combined mixed approach may produce greater benefits than the individual or group interventions alone.
Eligibility
Primary outcome measure(s)
- Change in Endometriosis-Related Quality of Life (EHP-30 score) — Baseline (T1) and 5 months (T2)
Change in the EHP-30 total score between baseline and post-intervention. Higher scores indicate worse quality of life.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Lyon Sud - Hospices Civils de Lyon | Pierre-Bénite | France |
More Hospices Civils de Lyon trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07280052 on ClinicalTrials.gov ↗ ← All trials in France